|
|
Article: ANESTA RECEIVES ACTIQ APPROVAL IN THE UK.
- Article from:
- PR Newswire
- Article date:
- October 10, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PR Newswire, London, October, 10. This press release is transmitted on behalf of Anesta UK Ltd.
Henley On Thames, England -
Anesta UK Ltd., a wholly-owned subsidiary of Anesta Corp. (Nasdaq: NSTA) announced today that the Medicines Control Agency (MCA) in the United Kingdom has granted a marketing authorisation for Actiq(R) (oral transmucosal fentanyl citrate). Actiq is the first product approved in the UK which is specifically indicated for the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic pain. (Photo: http://www.newscom.com/cgi-bin/prnh/19990914/ANESTALOGO )
Elan Pharmaceuticals Ltd. (a ...